Work productivity loss in mild to moderate COPD: Lessons learned from the CanCOLD study

Riany De Sousa Sena; Sara Ahmed; Wan C. Tan; Pei Z. Li; Laura Labonté; Shawn D. Aaron; Andrea Benedetti; Kenneth R. Chapman; B. Walker; J. Mark Fitzgerald; Paul Hernandez; François Maltais; Darcy D. Marciniuk; Denis E. O'Donnell; Don D. Sin; Jean Bourbeau

doi:10.1183/13993003.01154-2017

Work productivity loss in mild to moderate COPD: Lessons learned from the CanCOLD study

Riany De Sousa Sena, Sara Ahmed, Wan C. Tan, Pei Z. Li, Laura Labonté, Shawn D. Aaron, Andrea Benedetti, Kenneth R. Chapman, B. Walker, J. Mark Fitzgerald, Paul Hernandez, François Maltais, Darcy D. Marciniuk, Denis E. O'Donnell, Don D. Sin, Jean Bourbeau

Medicine

Medicine

Producción científica: Contribución a una revista › Carta › revisión exhaustiva

11 Citas (Scopus)

Idioma original	English
Número de artículo	01154
Publicación	European Respiratory Journal
Volumen	50
N.º	3
DOI	https://doi.org/10.1183/13993003.01154-2017
Estado	Published - sep. 1 2017

Nota bibliográfica

Funding Information:
Support statement: The Canadian Cohort Obstructive Lung Disease (CanCOLD) study is currently funded by the Canadian Respiratory Research Network (CRRN); industry partners: Astra Zeneca Canada Ltd; Boehringer Ingelheim Canada Ltd; GlaxoSmithKline Canada Ltd; and Novartis. Researchers at RI-MUHC Montreal and Icapture Centre Vancouver lead the project. Previous funding partners are the CIHR (CIHR/Rx&D Collaborative Research Program Operating Grants 93326); the Respiratory Health Network of the Fonds de la recherche en santé du Québec (FRSQ); industry partners: Almirall; Merck Nycomed; Pfizer Canada Ltd; and Theratechnologies. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. Funding information for this article has been deposited with the Crossref Funder Registry.

ASJC Scopus Subject Areas

Pulmonary and Respiratory Medicine

Acceder al documento

10.1183/13993003.01154-2017

Otros archivos y enlaces

Citar esto

De Sousa Sena, R., Ahmed, S., Tan, W. C., Li, P. Z., Labonté, L., Aaron, S. D., Benedetti, A., Chapman, K. R., Walker, B., Fitzgerald, J. M., Hernandez, P., Maltais, F., Marciniuk, D. D., O'Donnell, D. E., Sin, D. D., & Bourbeau, J. (2017). Work productivity loss in mild to moderate COPD: Lessons learned from the CanCOLD study. European Respiratory Journal, 50(3), Artículo 01154. https://doi.org/10.1183/13993003.01154-2017

De Sousa Sena, R, Ahmed, S, Tan, WC, Li, PZ, Labonté, L, Aaron, SD, Benedetti, A, Chapman, KR, Walker, B, Fitzgerald, JM, Hernandez, P, Maltais, F, Marciniuk, DD, O'Donnell, DE, Sin, DD & Bourbeau, J 2017, 'Work productivity loss in mild to moderate COPD: Lessons learned from the CanCOLD study', European Respiratory Journal, vol. 50, n.º 3, 01154. https://doi.org/10.1183/13993003.01154-2017

@article{4c2dbc61aa164a8796f952a75e0d519c,

title = "Work productivity loss in mild to moderate COPD: Lessons learned from the CanCOLD study",

author = "{De Sousa Sena}, Riany and Sara Ahmed and Tan, {Wan C.} and Li, {Pei Z.} and Laura Labont{\'e} and Aaron, {Shawn D.} and Andrea Benedetti and Chapman, {Kenneth R.} and B. Walker and Fitzgerald, {J. Mark} and Paul Hernandez and Fran{\c c}ois Maltais and Marciniuk, {Darcy D.} and O'Donnell, {Denis E.} and Sin, {Don D.} and Jean Bourbeau",

note = "Funding Information: Support statement: The Canadian Cohort Obstructive Lung Disease (CanCOLD) study is currently funded by the Canadian Respiratory Research Network (CRRN); industry partners: Astra Zeneca Canada Ltd; Boehringer Ingelheim Canada Ltd; GlaxoSmithKline Canada Ltd; and Novartis. Researchers at RI-MUHC Montreal and Icapture Centre Vancouver lead the project. Previous funding partners are the CIHR (CIHR/Rx&D Collaborative Research Program Operating Grants 93326); the Respiratory Health Network of the Fonds de la recherche en sant{\'e} du Qu{\'e}bec (FRSQ); industry partners: Almirall; Merck Nycomed; Pfizer Canada Ltd; and Theratechnologies. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. Funding information for this article has been deposited with the Crossref Funder Registry.",

year = "2017",

month = sep,

day = "1",

doi = "10.1183/13993003.01154-2017",

language = "English",

volume = "50",

journal = "European Respiratory Journal",

issn = "0903-1936",

publisher = "European Respiratory Society",

number = "3",

}

TY - JOUR

T1 - Work productivity loss in mild to moderate COPD

T2 - Lessons learned from the CanCOLD study

AU - De Sousa Sena, Riany

AU - Ahmed, Sara

AU - Tan, Wan C.

AU - Li, Pei Z.

AU - Labonté, Laura

AU - Aaron, Shawn D.

AU - Benedetti, Andrea

AU - Chapman, Kenneth R.

AU - Walker, B.

AU - Fitzgerald, J. Mark

AU - Hernandez, Paul

AU - Maltais, François

AU - Marciniuk, Darcy D.

AU - O'Donnell, Denis E.

AU - Sin, Don D.

AU - Bourbeau, Jean

N1 - Funding Information: Support statement: The Canadian Cohort Obstructive Lung Disease (CanCOLD) study is currently funded by the Canadian Respiratory Research Network (CRRN); industry partners: Astra Zeneca Canada Ltd; Boehringer Ingelheim Canada Ltd; GlaxoSmithKline Canada Ltd; and Novartis. Researchers at RI-MUHC Montreal and Icapture Centre Vancouver lead the project. Previous funding partners are the CIHR (CIHR/Rx&D Collaborative Research Program Operating Grants 93326); the Respiratory Health Network of the Fonds de la recherche en santé du Québec (FRSQ); industry partners: Almirall; Merck Nycomed; Pfizer Canada Ltd; and Theratechnologies. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. Funding information for this article has been deposited with the Crossref Funder Registry.

PY - 2017/9/1

Y1 - 2017/9/1

UR - http://www.scopus.com/inward/record.url?scp=85030032244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030032244&partnerID=8YFLogxK

U2 - 10.1183/13993003.01154-2017

DO - 10.1183/13993003.01154-2017

M3 - Letter

C2 - 28899939

AN - SCOPUS:85030032244

SN - 0903-1936

VL - 50

JO - European Respiratory Journal

JF - European Respiratory Journal

IS - 3

M1 - 01154

ER -